Publications by authors named "Sandra Vergo"

Claim this Profile
D
Drug Development.
Chase Redd, Nathaniel Guanzon, Yessenia Gallegos, Camilla Stampe Jensen, Sandra B Vergo

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin receptor-binding blood-brain barrier shuttle enhances brain delivery and plaque-clearing efficacy of a therapeutic anti-Aβ antibody.
Marta Ramos Vega, Henrik H Hansen, Camilla Stampe Jensen, Evdoxia Alexiou, Martin R Madsen, Sandra Vergo

Fluids Barriers CNS· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies.
Pekka Kallunki, Florence Sotty, Katarina Willén, Michal Lubas, Laurent David, Sandra Vergo

NPJ Parkinsons Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling a Human Blood-Brain Barrier Co-Culture Using an Ultrathin Silicon Nitride Membrane-Based Microfluidic Device.
Diana Hudecz, Molly C McCloskey, Sandra Vergo, Søren Christensen, James L McGrath

Int J Mol Sci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating IL-21 as a Potential Therapeutic Target in Crohn's Disease.
Thomas Lindebo Holm, Ditte Tornehave, Henrik Søndergaard, Peter Helding Kvist, Bodil-Cecilie Sondergaard, Sandra Vergo

Gastroenterol Res Pract· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
Tarunya Arun, Valentina Tomassini, Emilia Sbardella, Michiel B de Ruiter, Lucy Matthews, Sandra Vergo

Brain· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Sandra Vergo, Matthew J Craner, Ruth Etzensperger, Kathrine Attfield, Manuel A Friese

Brain· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Manuel A Friese, Matthew J Craner, Ruth Etzensperger, Sandra Vergo, John A Wemmie

Nat Med· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
Sandra Vergo, Jens Leander Johansen, Marcel Leist, Julie Lotharius

Brain Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of gephyrin assembly and glycine receptor synaptic stability.
Cécile Bedet, Jo C Bruusgaard, Sandra Vergo, Line Groth-Pedersen, Stefan Eimer

J Biol Chem· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis